Blog

Categories

Delivering Excellence in China End-to-End Services Jenny Zhang Delivering Excellence in China
In 2015 the China Food and Drug Administration (CFDA) ordered companies responsible for 1600+ new drug applications in China to conduct a “self-examination on the authenticity, integrity and...
 Using Gene Signature Methodologies to strengthen Immuno Oncology Trials Genomics Victor Weigman, Ph.D. Using Gene Signature Methodologies to strengthen Immuno Oncology Trials
The theme for this year’s World Cancer Day highlights the part we can all play in the fight against cancer. “We can. I can.” is a call to action for individuals and groups to contribute what they...
 The End to End Importance of Selecting the Right Biomarker in Cancer Studies End-to-End Services Biomarkers Patrick Hurban, Ph.D. The End to End Importance of Selecting the Right Biomarker in Cancer Studies
Researchers, healthcare providers, patients, families and friends join together on World Cancer Day to reaffirm our commitment to a unified fight against a disease that affects billions of people...
 It's complicated Clinical Trials Steven Lobel, PhD, D-ABMLI, MBA, FACB It's complicated
Diabetes is fast becoming a global healthcare epidemic. The number of people with diabetes rose from 108 million in 1980 to 422 million in 2014, with related deaths projected to rise by more than 50...
 Vaccines for Ebola Central Laboratories Vaccines Default Author Vaccines for Ebola
The 2014 Ebola crisis unfolded like a Hollywood movie, with gruesome deaths, tragic stories, and global panic about its potential spread. Ebola had never spread so far or fast in the known history of...
 Waging War of TB Central Laboratories Infectious Diseases Ayaskant Pany, MD Waging War of TB
Despite the fact that tuberculosis (TB) has been curable, it has become a global epidemic that impacts more people every year than HIV/AIDS. The millions of TB patients worldwide suffer from...
 Immunotherapy and PD-L1: A primer Biomarkers Companion Diagnostics Radha Krishnan Immunotherapy and PD-L1: A primer
Advances in precision medicine have led to a shift in paradigm for oncology research, from targeted therapies that rely largely on tyrosine kinase inhibitors (TKIs) to personalized therapy that can...
 Fighting cancer takes precision Genomics Precision Medicine Patrice Hugo, Ph.D. Fighting cancer takes precision
On February 4, we commemorated World Cancer Day, a day when researchers, physicians, patients and other interested groups acknowledge all the hard work being done to fight this global disease. This...
 Immunotherapy takes center stage on World Cancer Day Clinical Trials Central Laboratories Kathleen Gray Immunotherapy takes center stage on World Cancer Day
Author: Kathleen Gray, PhDThis is an exciting time to be working in the field of cancer research. Throughout the last few years, amazing strides have been made toward the ultimate goal: to turn...
 Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options by Victor Weigman Genomics Precision Medicine Victor Weigman, Ph.D. Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options by Victor Weigman
Authors: Victor Weigman, Ph.D. & Patrice Hugo, Ph.D.With advancements in clinical informatics and genomics, there has been a paradigm shift from “one drug fits all” toward precision medicine – taking...